Latest Production News

Anax Metals has locked in a $3.3 million convertible note investment from Mineral Development Partners, with conditional commitments for up to $100 million to advance the Whim Creek Project and establish a Pilbara base metals hub.

Conrad Asia Energy has successfully raised approximately A$9 million through a two-tranche placement, with strong insider participation, to fund key milestones in its flagship Mako gas development and other projects.

Critica Limited has secured drilling approvals and government funding to explore high-grade heavy rare earth elements at its Aurora and Juno satellite prospects near the flagship Jupiter deposit in Western Australia.

4DMedical has landed a significant commercial contract with Intermountain Health to deploy its FDA-cleared Pulmonary Hypertension Analysis (PHA™) product, marking a key milestone in its U.S. expansion through a strategic Microsoft-backed partnership.

ABx Group has discovered a new rare earth element province 52 km east of its Deep Leads resource in northern Tasmania, revealing exceptionally high grades of terbium and dysprosium critical for advanced technologies. This discovery aligns with shifting global supply dynamics amid US incentives and Chinese export restrictions.

Bio-Gene Technology Limited has raised $2.1 million through a placement and launched a Share Purchase Plan to fund critical safety studies for its flagship insecticide Flavocide®, alongside development of Qcide and strategic initiatives.

Stellar Resources reports strong high-grade tin intercepts at Queen Hill, underpinning potential resource upgrades and advancing the Heemskirk Tin Project towards development.

Enlitic, Inc. has launched a two-tranche institutional placement to raise A$10 million, underpinning its strategic collaboration with GE HealthCare and fueling expansion in AI-enabled medical imaging data migration.

Enlitic has formalised a binding MOU with GE HealthCare to deliver multi-million-dollar migration services, contingent on raising A$10 million through a new capital placement. This partnership and funding round mark a pivotal step in Enlitic’s growth strategy within AI-driven medical imaging.

Global uranium enrichment leader Urenco has agreed to invest A$5 million in Australian technology developer Ubaryon, forming a strategic partnership that validates and accelerates a novel uranium enrichment process.

AdAlta Limited has announced a pro rata renounceable rights offer to raise approximately $1.29 million, aiming to fund its strategic pivot towards licensing CAR-T cell therapies through its subsidiary AdCella. The offer includes new shares and options, underpinned by key insiders and an underwriting agreement.

Anagenics Ltd has reported a significant earnings turnaround in 3Q25 following a strategic business restructure, alongside securing a multi-year royalty agreement worth $4.4 million with York Street Brands.